REGULATED PRESS RELEASE published on 03/26/2024 at 08:30, 1 year 8 months ago Cie du Bois Sauvage: Terugkoop van eigen aandelen – Week van 18/03/2024 tot 22/03/2024 Compagnie du Bois Sauvage voert succesvol terugkoop van eigen aandelen uit, in lijn met buitengewone algemene vergadering. Transacties van 18/03/2024 tot 22/03/2024: 1.576 aandelen teruggekocht NYSE Euronext Brussel Financiële Informatie Compagnie Du Bois Sauvage Transacties Terugkoop Eigen Aandelen
REGULATED PRESS RELEASE published on 03/26/2024 at 08:30, 1 year 8 months ago Cie du Bois Sauvage : Rachat d’actions propres – semaine du 18/03/2024 au 22/03/2024 La Compagnie du Bois Sauvage annonce le rachat d'actions propres du 18/03/2024 au 22/03/2024, conformément à l'AG du 28/04/2021 Rachat D'actions Transactions NYSE Euronext Bruxelles Compagnie Du Bois Sauvage Autorisation AG
REGULATED PRESS RELEASE published on 03/26/2024 at 08:30, 1 year 8 months ago Cie du Bois Sauvage: Buy back of own shares – week from 18/03/2024 to 22/03/2024 Cie du Bois Sauvage discloses buy-back of own shares for the week of 18/03/2024 to 22/03/2024, totaling €389,955.00. Details available on www.bois-sauvage.be Cie Du Bois Sauvage Trading Disclosure NYSE Euronext Market Brussels Own Shares Buy-back
PRESS RELEASE published on 03/26/2024 at 08:27, 1 year 8 months ago Après une année 2023 fructueuse avec un nouveau capital de 1,7 milliard d'euros, Golding élargit son cercle de partenaires en la personne de Richard Wilmes, Head of Secondaries Golding Capital Partners élargit son cercle de partenaires avec Richard Wilmes, Head of Secondaries, après une année fructueuse en 2023 avec 1,7 milliard d'euros de nouveaux capitaux Investissements Fonds Secondaries Richard Wilmes Partenaires
PRESS RELEASE published on 03/26/2024 at 08:27, 1 year 8 months ago After a successful year 2023 with €1.7 billion in new capital raised, Golding promotes Richard Wilmes, Head of Secondaries, to new partner Golding Capital Partners promotes Richard Wilmes to new partner after successful 2023 with €1.7 billion raised, emphasizing the significance of transaction-oriented investments Capital Raising Golding Capital Partners Richard Wilmes New Partner Transaction-oriented Investments
PRESS RELEASE published on 03/26/2024 at 08:22, 1 year 8 months ago Correction of a release from 25/03/2024, 17:30 CET/CEST - SURTECO GROUP SE: Preliminary result for the business year 2023 SURTECO GROUP SE reports preliminary results for the business year 2023, with consolidated net sales of €835.1 million and EBITDA of €66.6 million. Details on integration of Omnova divisions and future outlook shared EBITDA Preliminary Results Business Year 2023 SURTECO GROUP SE Omnova Divisions
PRESS RELEASE published on 03/26/2024 at 08:15, 1 year 8 months ago EQS-Adhoc: AQUEDUCT EUROPEAN CLO 8 DESIGNATED ACTIVITY COMPANY: COMPANY ANNOUNCEMENT AQUEDUCT EUROPEAN CLO 8 DESIGNATED ACTIVITY COMPANY announces changes to warehouse arrangements. Deed of Amendment signed on 20 March 2024 AQUEDUCT EUROPEAN CLO 8 Warehouse Facility Deed Deed Of Amendment Designated Activity Company Borrower
PRESS RELEASE published on 03/26/2024 at 08:14, 1 year 8 months ago MBB SE expects one billion euros in revenue with an EBITDA margin of 10% in 2024 MBB SE expects one billion euros in revenue with an EBITDA margin of 10% in 2024. The Group's diversified segments show varying performance in the 2023 financial year Financial Performance 2024 Outlook Revenue Forecast EBITDA Margin MBB SE
PRESS RELEASE published on 03/26/2024 at 08:01, 1 year 8 months ago Original-Research: Surteco Group SE (von Sphene Capital GmbH): Buy Sphene Capital GmbH bestätigt Kaufempfehlung fÜr Surteco Group SE mit unverändertem Kursziel von EUR 26,50. VorlÄufige Zahlen 2023 bestÄtigen Erwartungen. Prognose fÜr GeschÄftsjahr 2024 positiv Kursziel Kaufempfehlung Sphene Capital GmbH SURTECO GROUP SE Jahreszahlen
PRESS RELEASE published on 03/26/2024 at 08:00, 1 year 8 months ago BIOSYNEX SA: AVALUN LAURÉATE DES TROPHÉES DE LA HEALTHTECH POUR LE DÉVELOPPEMENT DE SON NOUVEAU TEST DE MESURE RAPIDE DU FIBRINOGÈNE AVALUN, filiale de BIOSYNEX, remporte le Trophée de la HealthTech pour son nouveau test de mesure rapide du fibrinogène. Le produit vise à améliorer les prises en charge d'urgence des hémorragies sévères BIOSYNEX AVALUN Trophée De La HealthTech Test De Mesure Rapide Fibrinogène
Published on 12/20/2025 at 00:30, 1 hour 11 minutes ago Alphinat Announces a Profit of $120,155 for Fiscal Year Ended August 31, 2025
Published on 12/19/2025 at 22:00, 3 hours 41 minutes ago GMV Minerals Inc. Closes Non-Brokered Equity Financing
Published on 12/19/2025 at 18:30, 7 hours 11 minutes ago Eagle Plains Shareholders Approve all Matters at Annual General Meeting
Published on 12/19/2025 at 14:40, 11 hours 1 minute ago Northern Superior Announces Closing of the Arrangement
Published on 12/19/2025 at 13:30, 12 hours 11 minutes ago Quartz Commences Trading On The OTCQX Best Market Under The Symbol QZMRF
Published on 12/19/2025 at 22:03, 3 hours 38 minutes ago EAMD: Trading resumes on the Düsseldorf Stock Exchange, lawsuit filed by minority shareholders dismissed, capital increase for investments in drone projects in the defense tech sector
Published on 12/19/2025 at 21:40, 4 hours ago IMG Saxony-Anhalt: 2026 in Sight - Saxony-Anhalt Sets the Pace for Future Industries
Published on 12/19/2025 at 20:35, 5 hours 5 minutes ago Nobu Manchester breaks ground as Robert De Niro visits Manchester with Salboy
Published on 12/19/2025 at 19:56, 5 hours 44 minutes ago Original-Research: European Lithium Limited (von First Berlin Equity Research GmbH): Buy
Published on 12/19/2025 at 21:57, 3 hours 43 minutes ago Mise à disposition du document d’enregistrement universel
Published on 12/19/2025 at 08:30, 17 hours 11 minutes ago Share capital decrease by way of treasury shares cancellation
Published on 12/19/2025 at 08:30, 17 hours 11 minutes ago Réduction du capital par voie d’annulation d’actions propres
Published on 12/19/2025 at 07:00, 18 hours 41 minutes ago EURAZEO ANNONCE AVOIR MENÉ AVEC SUCCÈS UNE TRANSACTION ACCÉLÉRANT SA ROTATION D'ACTIFS
Published on 12/19/2025 at 07:00, 18 hours 41 minutes ago EURAZEO ANNOUNCES A SUCCESSFUL TRANSACTION ACCELERATING ITS ASSET ROTATION